Literature DB >> 33159200

Risk Factors for Cytomegalovirus Reactivation and Association With Outcomes in Critically Ill Adults With Sepsis: A Pooled Analysis of Prospective Studies.

Hannah Imlay1,2,3, Sayan Dasgupta2, Michael Boeckh1,2, Renee D Stapleton4, Gordon D Rubenfeld5, Ying Chen2, Ajit P Limaye1.   

Abstract

We performed multivariable analysis of potential risk factors (including cytomegalovirus [CMV] reactivation) for clinical outcomes by day 28 (death or continued hospitalization, ventilator-free days, intensive care unit (ICU)-free days, hospital-free days) from pooled cohorts of 2 previous prospective studies of CMV-seropositive adults with sepsis. CMV reactivation at any level, >100 IU/mL, >1000 IU/mL, peak viral load, and area under the curve were independently associated with the clinical outcomes. We identified the potential effect size of CMV on outcomes that could be used as end points for future interventional trials of CMV prevention using antiviral prophylaxis in ICU patients with sepsis.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  critical illness; cytomegalovirus; mechanical ventilation; sepsis

Mesh:

Year:  2021        PMID: 33159200      PMCID: PMC8496661          DOI: 10.1093/infdis/jiaa697

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Strong Cell-Mediated Immune Response to Human Cytomegalovirus Is Associated With Increased Risk of Fetal Infection in Primarily Infected Pregnant Women.

Authors:  Alda Saldan; Gabriella Forner; Carlo Mengoli; Nadia Gussetti; Giorgio Palù; Davide Abate
Journal:  Clin Infect Dis       Date:  2015-07-14       Impact factor: 9.079

2.  Effect of Ganciclovir on IL-6 Levels Among Cytomegalovirus-Seropositive Adults With Critical Illness: A Randomized Clinical Trial.

Authors:  Ajit P Limaye; Renee D Stapleton; Lili Peng; Scott R Gunn; Louise E Kimball; Robert Hyzy; Matthew C Exline; D Clark Files; Peter E Morris; Stephen K Frankel; Mark E Mikkelsen; Duncan Hite; Kyle B Enfield; Jay Steingrub; James O'Brien; Polly E Parsons; Joseph Cuschieri; Richard G Wunderink; David L Hotchkin; Ying Q Chen; Gordon D Rubenfeld; Michael Boeckh
Journal:  JAMA       Date:  2017-08-22       Impact factor: 56.272

3.  Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome.

Authors:  David A Schoenfeld; Gordon R Bernard
Journal:  Crit Care Med       Date:  2002-08       Impact factor: 7.598

Review 4.  Cytomegalovirus pneumonia in hematopoietic stem cell recipients.

Authors:  Giovanna Travi; Steven A Pergam
Journal:  J Intensive Care Med       Date:  2013-02-06       Impact factor: 3.510

5.  Cytomegalovirus reactivation in critically ill immunocompetent patients.

Authors:  Ajit P Limaye; Katharine A Kirby; Gordon D Rubenfeld; Wendy M Leisenring; Eileen M Bulger; Margaret J Neff; Nicole S Gibran; Meei-Li Huang; Tracy K Santo Hayes; Lawrence Corey; Michael Boeckh
Journal:  JAMA       Date:  2008-07-23       Impact factor: 56.272

6.  Cytomegalovirus reactivation and associated outcome of critically ill patients with severe sepsis.

Authors:  Alexandra Heininger; Helene Haeberle; Imma Fischer; Robert Beck; Reimer Riessen; Frank Rohde; Christoph Meisner; Gerhard Jahn; Alfred Koenigsrainer; Klaus Unertl; Klaus Hamprecht
Journal:  Crit Care       Date:  2011-03-01       Impact factor: 9.097

7.  Association Between Cytomegalovirus Reactivation and Clinical Outcomes in Immunocompetent Critically Ill Patients: A Systematic Review and Meta-Analysis.

Authors:  Philippe Lachance; Justin Chen; Robin Featherstone; Wendy I Sligl
Journal:  Open Forum Infect Dis       Date:  2017-02-13       Impact factor: 3.835

8.  Cytomegalovirus reactivation in ICU patients.

Authors:  Laurent Papazian; Sami Hraiech; Samuel Lehingue; Antoine Roch; Laurent Chiche; Sandrine Wiramus; Jean-Marie Forel
Journal:  Intensive Care Med       Date:  2015-09-30       Impact factor: 17.440

9.  Reactivation of multiple viruses in patients with sepsis.

Authors:  Andrew H Walton; Jared T Muenzer; David Rasche; Jonathan S Boomer; Bryan Sato; Bernard H Brownstein; Alexandre Pachot; Terrence L Brooks; Elena Deych; William D Shannon; Jonathan M Green; Gregory A Storch; Richard S Hotchkiss
Journal:  PLoS One       Date:  2014-06-11       Impact factor: 3.240

10.  Cytomegalovirus reactivation and mortality in patients with acute respiratory distress syndrome.

Authors:  David S Y Ong; Cristian Spitoni; Peter M C Klein Klouwenberg; Frans M Verduyn Lunel; Jos F Frencken; Marcus J Schultz; Tom van der Poll; Jozef Kesecioglu; Marc J M Bonten; Olaf L Cremer
Journal:  Intensive Care Med       Date:  2015-09-28       Impact factor: 17.440

View more
  3 in total

1.  Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality.

Authors:  Ilenia Gatto; Emanuela Biagioni; Irene Coloretti; Carlotta Farinelli; Camilla Avoni; Valeria Caciagli; Stefano Busani; Mario Sarti; Monica Pecorari; William Gennari; Giovanni Guaraldi; Erica Franceschini; Marianna Meschiari; Cristina Mussini; Roberto Tonelli; Enrico Clini; Andrea Cossarizza; Massimo Girardis
Journal:  Intensive Care Med       Date:  2022-05-18       Impact factor: 41.787

Review 2.  The Contribution of Human Herpes Viruses to γδ T Cell Mobilisation in Co-Infections.

Authors:  Fanny Martini; Eric Champagne
Journal:  Viruses       Date:  2021-11-26       Impact factor: 5.048

3.  Association between active cytomegalovirus infection and lung fibroproliferation in adult patients with acute respiratory distress syndrome: a retrospective study.

Authors:  Zhihui Zhang; Rujian Li; Xiaoqing Liu; Yimin Li; Yubiao Chen; Jierong Zhang; Yongxin Zheng; Minmin Xu; Jiaqi Liang; Jiahui Li; Yongbo Huang; Yonghao Xu; Weiqun He
Journal:  BMC Infect Dis       Date:  2022-10-14       Impact factor: 3.667

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.